For more information or to request samples, please email us at [email protected], call us at 855 388 2800 or fill in our online form
But anyone marketing it as a proven enhancement to tirzepatide efficacy is getting ahead of the science
Equally important, however, is the maintenance of bodyweight reduction to sustain these benefits, which remains challenging for many patients
A 2023 study published in JAMA found that patients using GLP-1 receptor agonists for weight loss had a significantly higher risk of gastroparesis, pancreatitis, and bowel obstruction compared to those using other weight loss medications
GLP-1 medications are meant to be taken long-term alongside lifestyle changes, under a healthcare providers supervision, and only for those who meet specific criteria
Establish a rotation schedule and stick to it